Kerala Ayurveda Ltd
BSE:530163
Kerala Ayurveda Ltd
BSE:530163
Price:
172.85
INR
2.31%
Market Closed
Market Cap:
₹2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kerala Ayurveda Ltd
BSE:530163
|
IN |
|
Astaka Holdings Ltd
SGX:42S
|
MY |
|
Michelmersh Brick Holdings PLC
LSE:MBH
|
UK |
|
Squarespace Inc
NYSE:SQSP
|
US |
Relative Value
The Relative Value of one
KERALAYUR
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 172.85 INR,
Kerala Ayurveda Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KERALAYUR Relative Value
HIDDEN
Multiples Across Competitors
KERALAYUR Competitors Multiples
Kerala Ayurveda Ltd Competitors
Kerala Ayurveda Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Kerala Ayurveda Ltd
BSE:530163
|
2.1B INR | 1.6 | -8.8 | -10.4 | -8.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.2 | 41.8 | 28.2 | 30.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 4.9 | 28.4 | 15.8 | 22.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.5 | 16.8 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
